PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mirnezami, R; Nicholson, J; Darzi, A				Mirnezami, Reza; Nicholson, Jeremy; Darzi, Ara			Preparing for Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Mirnezami, Reza; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Sect Biosurg & Surg Technol, Dept Surg & Canc, London, England; [Nicholson, Jeremy] Univ London Imperial Coll Sci Technol & Med, Sect Biomol Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Mirnezami, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Biosurg & Surg Technol, Dept Surg & Canc, London, England.		Nicholson, Jeremy K/B-3395-2012	Nicholson, Jeremy K/0000-0002-8123-8349				Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Katsanis SH, 2008, SCIENCE, V320, P53, DOI 10.1126/science.1156604; Mayor S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6215; Scheuner MT, 2009, GENET MED, V11, P510, DOI 10.1097/GIM.0b013e3181a53331	4	440	468	5	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					489	491		10.1056/NEJMp1114866	http://dx.doi.org/10.1056/NEJMp1114866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22256780				2022-12-01	WOS:000299991300004
J	Ng, SW; Bakowski, D; Nelson, C; Mehta, R; Almeyda, R; Bates, G; Parekh, AB				Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Almeyda, Robert; Bates, Grant; Parekh, Anant B.			Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression	NATURE			English	Article							ACTIVATED CALCIUM CURRENT; BASOPHILIC LEUKEMIA-CELLS; TYROSINE KINASE SYK; DEPENDENT INACTIVATION; FEEDBACK INHIBITION; CA2+ CHANNELS; RBL-2H3 CELLS; C-FOS; CRAC; EXOCYTOSIS	Receptor desensitization is a universal mechanism to turn off a biological response; in this process, the ability of a physiological trigger to activate a cell is lost despite the continued presence of the stimulus. Receptor desensitization of G-protein-coupled receptors involves uncoupling of the receptor from its G-protein or second-messenger pathway followed by receptor internalization(1). G-protein-coupled cysteinyl leukotriene type I (CysLT1) receptors regulate immune-cell function and CysLT1 receptors are an established therapeutic target for allergies, including asthma(2). Desensitization of CysLT1 receptors arises predominantly from protein-kinase-C-dependent phosphorylation of three serine residues in the receptor carboxy terminus(3). Physiological concentrations of the receptor agonist leukotriene C-4 (LTC4) evoke repetitive cytoplasmic Ca2+ oscillations, reflecting regenerative Ca2+ release from stores, which is sustained by Ca2+ entry through store-operated calcium-release-activated calcium (CRAC) channels(4). CRAC channels are tightly linked to expression of the transcription factor c-fos(5), a regulator of numerous genes important to cell growth and development(6). Here we show that abolishing leukotriene receptor desensitization suppresses agonist-driven gene expression in a rat cell line. Mechanistically, stimulation of non-desensitizing receptors evoked prolonged inositol-trisphosphate-mediated Ca2+ release, which led to accelerated Ca2+-dependent slow inactivation of CRAC channels and a subsequent loss of excitation-transcription coupling. Hence, rather than serving to turn off a biological response, reversible desensitization of a Ca2+ mobilizing receptor acts as an 'on' switch, sustaining long-term signalling in the immune system.	[Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Almeyda, Robert; Bates, Grant] John Radcliffe Hosp, Dept Ear Nose Throat Surg, Oxford OX3 9DH, England	University of Oxford; University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Mehta, Ravi/0000-0001-8211-1721	Medical Research Council; BBSRC-Glaxo-Smith-Kline; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-Glaxo-Smith-Kline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council grant support to A. B. P. S.-W. N. held a BBSRC-Glaxo-Smith-Kline studentship. We thank G. Miesenboeck and J. Putney for comments on the manuscript.	Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Di Capite J, 2009, J ALLERGY CLIN IMMUN, V124, P1014, DOI 10.1016/j.jaci.2009.08.030; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Di Capite J, 2009, FASEB J, V23, P894, DOI 10.1096/fj.08-118935; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; OZAWA K, 1993, J BIOL CHEM, V268, P2280; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RAZIN E, 1994, P NATL ACAD SCI USA, V91, P7722, DOI 10.1073/pnas.91.16.7722; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stephan V, 1997, CELL SIGNAL, V9, P65, DOI 10.1016/S0898-6568(96)00093-9; TAKASAKA T, 1986, ACTA OTO-LARYNGOL, P39; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	25	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					111	U144		10.1038/nature10731	http://dx.doi.org/10.1038/nature10731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22230957	Green Accepted			2022-12-01	WOS:000299726000046
J	Welsh, WF; Orosz, JA; Carter, JA; Fabrycky, DC; Ford, EB; Lissauer, JJ; Prsa, A; Quinn, SN; Ragozzine, D; Short, DR; Torres, G; Winn, JN; Doyle, LR; Barclay, T; Batalha, N; Bloemen, S; Brugamyer, E; Buchhave, LA; Caldwell, C; Caldwell, DA; Christiansen, JL; Ciardi, DR; Cochran, WD; Endl, M; Fortney, JJ; Gautier, TN; Gilliland, RL; Haas, MR; Hall, JR; Holman, MJ; Howard, AW; Howell, SB; Isaacson, H; Jenkins, JM; Klaus, TC; Latham, DW; Li, J; Marcy, GW; Mazeh, T; Quintana, EV; Robertson, P; Shporer, A; Steffen, JH; Windmiller, G; Koch, DG; Borucki, WJ				Welsh, William F.; Orosz, Jerome A.; Carter, Joshua A.; Fabrycky, Daniel C.; Ford, Eric B.; Lissauer, Jack J.; Prsa, Andrej; Quinn, Samuel N.; Ragozzine, Darin; Short, Donald R.; Torres, Guillermo; Winn, Joshua N.; Doyle, Laurance R.; Barclay, Thomas; Batalha, Natalie; Bloemen, Steven; Brugamyer, Erik; Buchhave, Lars A.; Caldwell, Caroline; Caldwell, Douglas A.; Christiansen, Jessie L.; Ciardi, David R.; Cochran, William D.; Endl, Michael; Fortney, Jonathan J.; Gautier, Thomas N., III; Gilliland, Ronald L.; Haas, Michael R.; Hall, Jennifer R.; Holman, Matthew J.; Howard, Andrew W.; Howell, Steve B.; Isaacson, Howard; Jenkins, Jon M.; Klaus, Todd C.; Latham, David W.; Li, Jie; Marcy, Geoffrey W.; Mazeh, Tsevi; Quintana, Elisa V.; Robertson, Paul; Shporer, Avi; Steffen, Jason H.; Windmiller, Gur; Koch, David G.; Borucki, William J.			Transiting circumbinary planets Kepler-34 b and Kepler-35 b	NATURE			English	Article							HIERARCHICAL TRIPLE; ECLIPSING BINARIES; STELLAR; STABILITY; CATALOG	Most Sun-like stars in the Galaxy reside in gravitationally bound pairs of stars(1,2) (binaries). Although long anticipated(3-8), the existence of a 'circumbinary planet' orbiting such a pair of normal stars was not definitively established until the discovery(9) of the planet transiting (that is, passing in front of) Kepler-16. Questions remained, however, about the prevalence of circumbinary planets and their range of orbital and physical properties. Here we report two additional transiting circumbinary planets: Kepler-34 (AB)b and Kepler-35 (AB)b, referred to here as Kepler-34 b and Kepler-35 b, respectively. Each is a low-density gas-giant planet on an orbit closely aligned with that of its parent stars. Kepler-34 b orbits two Sun-like stars every 289 days, whereas Kepler-35 b orbits a pair of smaller stars (89% and 81% of the Sun's mass) every 131 days. The planets experience large multi-periodic variations in incident stellar radiation arising from the orbital motion of the stars. The observed rate of circumbinary planets in our sample implies that more than similar to 1% of close binary stars have giant planets in nearly coplanar orbits, yielding a Galactic population of at least several million.	[Welsh, William F.; Orosz, Jerome A.; Short, Donald R.; Windmiller, Gur] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Fabrycky, Daniel C.] Univ Calif Santa Cruz, Lick Observ, UCO, Santa Cruz, CA 95064 USA; [Ford, Eric B.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Lissauer, Jack J.; Barclay, Thomas; Batalha, Natalie; Christiansen, Jessie L.; Haas, Michael R.; Howell, Steve B.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.; Koch, David G.; Borucki, William J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Carter, Joshua A.; Quinn, Samuel N.; Ragozzine, Darin; Torres, Guillermo; Holman, Matthew J.; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Prsa, Andrej] Villanova Univ, Dept Astron & Astrophys, Villanova, PA 19085 USA; [Quinn, Samuel N.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA; [Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Doyle, Laurance R.; Caldwell, Douglas A.; Christiansen, Jessie L.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.] SETI Inst, Carl Sagan Ctr Study Life Universe, Mountain View, CA 94043 USA; [Barclay, Thomas] Bay Area Environm Res Inst Inc, Sonoma, CA 95476 USA; [Batalha, Natalie] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Bloemen, Steven] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Brugamyer, Erik; Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Gautier, Thomas N., III] Jet Prop Lab, Pasadena, CA 91109 USA; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Klaus, Todd C.] NASA, Orbital Sci Corp, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Mazeh, Tsevi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Shporer, Avi] Las Cumbres Observ, Global Telescope Network, Santa Barbara, CA 93117 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA	California State University System; San Diego State University; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Villanova University; University System of Georgia; Georgia State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California State University System; San Jose State University; KU Leuven; University of Copenhagen; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Space Telescope Science Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; Tel Aviv University; University of California System; University of California Santa Barbara	Welsh, WF (corresponding author), San Diego State Univ, Dept Astron, 5500 Campanile Dr, San Diego, CA 92182 USA.	wfw@sciences.sdsu.edu; jacarter@cfa.harvard.edu	Shporer, Avi/Y-2777-2019; Buchhave, Lars A./ABF-2000-2020; Robertson, Paul/AEV-0522-2022; Cochran, William D/M-4421-2014; Caldwell, Douglas A/L-7911-2014; Welsh, William/AAS-3445-2021; Steffen, Jason H./A-4320-2013; Ragozzine, Darin/C-4926-2013; Howard, Andrew/D-4148-2015; Marcy, Geoff/AAC-6050-2019; Carter, Joshua A/A-8280-2013; Ford, Eric B./AAB-5479-2019; Fortney, Jonathan/F-8813-2014	Shporer, Avi/0000-0002-1836-3120; Buchhave, Lars A./0000-0003-1605-5666; Robertson, Paul/0000-0003-0149-9678; Cochran, William D/0000-0001-9662-3496; Caldwell, Douglas A/0000-0003-1963-9616; Howard, Andrew/0000-0001-8638-0320; Ford, Eric B./0000-0001-6545-639X; Christiansen, Jessie/0000-0002-8035-4778; Barclay, Thomas/0000-0001-7139-2724; Fortney, Jonathan/0000-0002-9843-4354; Batalha, Natalie/0000-0002-7030-9519; Steffen, Jason/0000-0003-2202-3847; Fabrycky, Daniel/0000-0003-3750-0183; Ciardi, David/0000-0002-5741-3047	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF; NASA; STScI; European Research Council under the European Community; Research Council of KU Leuven; FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien [1109928] Funding Source: National Science Foundation	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute); European Research Council under the European Community(European Research Council (ERC)); Research Council of KU Leuven(KU Leuven); FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was selected as the tenth NASA Discovery mission with funding provided by NASA's Science Mission Directorate. We thank the many people who made the Kepler mission a reality. W. F. W., J.A.O., E. B. F., A. P., L. R. D., J.J.F., M.J.H., T. M. and J.H.S. were supported by the Kepler Participating Scientist Program. W. F. W., J.A.O., D. R. S. and G. W. were supported by the NSF. D. C. F. and J.A.C. acknowledge NASA support through Hubble Fellowship grants, awarded by STScI, operated by AURA. J.N.W. was supported by the NASA Origins programme. S. B. acknowledges funding from the European Research Council under the European Community's Seventh Framework Programme (PROSPERITY) and from the Research Council of KU Leuven. Some of the reported computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. This Letter is based in part on observations made with the Nordic Optical Telescope (operated on the island of La Palma jointly by Denmark, Finland, Iceland, Norway and Sweden, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias), the W. M. Keck Observatory (operated by the University of California and the California Institute of Technology) and the Hobby-Eberly Telescope (HET; a joint project of the University of Texas at Austin, the Pennsylvania State University, Stanford University, Ludwig-Maximillians-Universitat Munchen, and Georg-August-Universitat Goettingen).	Binnendijk L, 1960, PROPERTIES DOUBLE ST; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Deeg HJ, 2008, ASTRON ASTROPHYS, V480, P563, DOI 10.1051/0004-6361:20079000; Doolin S., 2011, NOT R ASTRO IN PRESS; Doyle LR, 2011, SCIENCE, V333, P1602, DOI 10.1126/science.1210923; EGGLETON P, 1995, ASTROPHYS J, V455, P640, DOI 10.1086/176611; Haghighipour N, 2010, ASTROPHYS SPACE SC L, V366, P285, DOI 10.1007/978-90-481-8687-7_11; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Quintana EV, 2006, ICARUS, V185, P1, DOI 10.1016/j.icarus.2006.06.016; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Ragozzine D., 2010, ASTROPHYS J UNPUB; SCHNEIDER J, 1990, ASTRON ASTROPHYS, V232, P251; Schwarz R, 2011, MON NOT R ASTRON SOC, V414, P2763, DOI 10.1111/j.1365-2966.2011.18594.x; Slawson RW, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/160; Sybilski P, 2010, MON NOT R ASTRON SOC, V405, P657, DOI 10.1111/j.1365-2966.2010.16490.x; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	22	319	323	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					475	U85		10.1038/nature10768	http://dx.doi.org/10.1038/nature10768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237021	Green Submitted, Green Accepted			2022-12-01	WOS:000299471800033
J	Hatcher, S; Arroll, B				Hatcher, Simon; Arroll, Bruce			THERAPEUTICS Newer antidepressants for the treatment of depression in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							2ND-GENERATION ANTIDEPRESSANTS; METAANALYSIS; OUTCOMES; SEVERITY; BENEFITS; DISORDER; ANXIETY; HARMS; RISK; CARE		[Hatcher, Simon] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand	University of Auckland	Hatcher, S (corresponding author), Univ Auckland, Dept Psychol Med, Private Bag 92019, Auckland 1, New Zealand.	s.hatcher@auckland.ac.nz						Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; [Anonymous], 2008, Drug Ther Bull, V46, P29, DOI 10.1136/dtb.2008.03.0009; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Arroll B, 2009, J PRIM HEALTH CARE, V1, P26, DOI 10.1071/HC09026; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cameron IM, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583209; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Hawton K, 2010, BRIT J PSYCHIAT, V196, P354, DOI 10.1192/bjp.bp.109.070219; Hetrick SE, 2010, CURR OPIN PSYCHIATR, V23, P53, DOI 10.1097/YCO.0b013e328334bc92; Horder J, 2010, J PSYCHOPHARMACOL; Kendrick T, 2009, HLTH TECHNOL ASSESS, V13; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Mark TL, 2011, AM J GERIAT PSYCHIAT, V19, P211, DOI 10.1097/JGP.0b013e3181f1803d; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; National Institute for Health and Clinical Excellence, 2009, TREATM MAN DEPR AD U; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Nease DE, 2003, J FAM PRACTICE, V52, P118; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P343, DOI 10.1177/0269881109105498; Pagura J, 2011, J CLIN PSYCHIAT, V72, P494, DOI 10.4088/JCP.09m05776blu; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Wu P, 2007, PSYCHIAT SERV, V58, P349, DOI 10.1176/appi.ps.58.3.349	33	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2012	344								d8300	10.1136/bmj.d8300	http://dx.doi.org/10.1136/bmj.d8300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888ZA	22262785				2022-12-01	WOS:000300042000007
J	Heravi-Moussavi, A; Anglesio, MS; Cheng, SWG; Senz, J; Yang, W; Prentice, L; Fejes, AP; Chow, C; Tone, A; Kalloger, SE; Hamel, N; Roth, A; Ha, G; Wan, ANC; Maines-Bandiera, S; Salamanca, C; Pasini, B; Clarke, BA; Lee, AF; Lee, CH; Zhao, CQ; Young, RH; Aparicio, SA; Sorensen, PHB; Woo, MMM; Boyd, N; Jones, SJM; Hirst, M; Marra, MA; Gilks, B; Shah, SP; Foulkes, WD; Morin, GB; Huntsman, DG				Heravi-Moussavi, Alireza; Anglesio, Michael S.; Cheng, S. -W. Grace; Senz, Janine; Yang, Winnie; Prentice, Leah; Fejes, Anthony P.; Chow, Christine; Tone, Alicia; Kalloger, Steve E.; Hamel, Nancy; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Pasini, Barbara; Clarke, Blaise A.; Lee, Anna F.; Lee, Cheng-Han; Zhao, Chengquan; Young, Robert H.; Aparicio, Samuel A.; Sorensen, Poul H. B.; Woo, Michelle M. M.; Boyd, Niki; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Gilks, Blake; Shah, Sohrab P.; Foulkes, William D.; Morin, Gregg B.; Huntsman, David G.			Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOSA-CELL TUMORS; EXPRESSION; MICRORNAS; PROGNOSIS; SELECTION; DROSHA; FOXL2	BACKGROUND Germline truncating mutations in DICER1, an endoribonuclease in the RNase III family that is essential for processing microRNAs, have been observed in families with the pleuropulmonary blastoma-family tumor and dysplasia syndrome. Mutation carriers are at risk for nonepithelial ovarian tumors, notably sex cord-stromal tumors. METHODS We sequenced the whole transcriptomes or exomes of 14 nonepithelial ovarian tumors and noted closely clustered mutations in the region of DICER1 encoding the RNase IIIb domain of DICER1 in four samples. We then sequenced this region of DICER1 in additional ovarian tumors and in certain other tumors and queried the effect of the mutations on the enzymatic activity of DICER1 using in vitro RNA cleavage assays. RESULTS DICER1 mutations in the RNase IIIb domain were found in 30 of 102 nonepithelial ovarian tumors (29%), predominantly in Sertoli-Leydig cell tumors (26 of 43, or 60%), including 4 tumors with additional germline DICER1 mutations. These mutations were restricted to codons encoding metal-binding sites within the RNase IIIb catalytic centers, which are critical for microRNA interaction and cleavage, and were somatic in all 16 samples in which germline DNA was available for testing. We also detected mutations in 1 of 14 nonseminomatous testicular germ-cell tumors, in 2 of 5 embryonal rhabdomyosarcomas, and in 1 of 266 epithelial ovarian and endometrial carcinomas. The mutant DICER1 proteins had reduced RNase IIIb activity but retained RNase IIIa activity. CONCLUSIONS Somatic missense mutations affecting the RNase IIIb domain of DICER1 are common in nonepithelial ovarian tumors. These mutations do not obliterate DICER1 function but alter it in specific cell types, a novel mechanism through which perturbation of microRNA processing may be oncogenic. (Funded by the Terry Fox Research Institute and others.)	[Huntsman, David G.] Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Vancouver, BC V5Z 4E6, Canada; [Heravi-Moussavi, Alireza; Cheng, S. -W. Grace; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Aparicio, Samuel A.; Sorensen, Poul H. B.; Jones, Steven J. M.; Marra, Marco A.; Shah, Sohrab P.; Morin, Gregg B.; Huntsman, David G.] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Chow, Christine; Kalloger, Steve E.; Gilks, Blake; Huntsman, David G.] Univ British Columbia, Vancouver Gen Hosp, Genet Pathol Evaluat Ctr, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Huntsman, David G.] Univ British Columbia, Ctr Translat & Appl Genom, British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Jones, Steven J. M.; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Anglesio, Michael S.; Lee, Anna F.; Lee, Cheng-Han; Aparicio, Samuel A.; Sorensen, Poul H. B.; Gilks, Blake; Shah, Sohrab P.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Cheng, S. -W. Grace; Fejes, Anthony P.; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Pasini, Barbara] Univ Turin, Dept Genet, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biol, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biochem, Turin, Italy; [Clarke, Blaise A.] Univ Toronto, Fac Med, Dept Lab Med, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Toronto, Dept Pathobiol, Fac Med, Toronto, ON, Canada; [Zhao, Chengquan] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Young, Robert H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Young, Robert H.] Harvard Univ, Sch Med, Boston, MA USA	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; McGill University; McGill University; British Columbia Cancer Agency; University of British Columbia; McGill University; Lady Davis Institute; McGill University; University of Turin; University of Turin; University of Turin; University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Huntsman, DG (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Rm 3427,600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	gmorin@bcgsc.ca; dhuntsma@bccancer.bc.ca	Hamel, Nancy/L-5122-2016; Morin, Gregg B/E-9123-2012; Ha, Gavin/N-1984-2019; Hirst, Martin/B-7684-2016; Huntsman, David/ABE-6082-2020; Marra, Marco A/B-5987-2008; Pasini, Barbara/AHI-2004-2022; Jones, Steven J/C-3621-2009; Foulkes, William D./AAR-9586-2021	Hamel, Nancy/0000-0001-8971-0428; Morin, Gregg B/0000-0001-8949-4374; Ha, Gavin/0000-0001-7578-7272; Marra, Marco A/0000-0001-7146-7175; Pasini, Barbara/0000-0002-4373-1212; Jones, Steven J/0000-0003-3394-2208; Foulkes, William D./0000-0001-7427-4651; Aparicio, Samuel/0000-0002-0487-9599; Clarke, Blaise/0000-0002-2585-8391; Anglesio, Michael/0000-0003-1639-5003; Lee, Anna/0000-0002-6703-0656	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research; Genome Canada; Michael Smith Foundation for Health Research; Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure; Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Supported by grants from the Terry Fox Research Institute, the British Columbia Cancer Foundation, the Vancouver General Hospital-University of British Columbia Hospital Foundation, the Canadian Institutes of Health Research, Genome Canada, the Michael Smith Foundation for Health Research, the Marsha Rivkin Centre for Ovarian Cancer Research, Susan G. Komen for the Cure, and the Weekend to End Women's Cancer. The contributing tumor banks were supported by the Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada, and the National Cancer Institute through the Cooperative Human Tissue Network and the Gynecologic Oncology Group.	Al-Agha OM, 2011, AM J SURG PATHOL, V35, P484, DOI 10.1097/PAS.0b013e31820a406c; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Colombo N, 2009, ANN ONCOL, V20, P24, DOI 10.1093/annonc/mdp118; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foulkes WD, 2011, HUM MUTAT, V32, P1381, DOI 10.1002/humu.21600; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; HORWICH A, 1991, J CLIN ONCOL, V9, P62, DOI 10.1200/JCO.1991.9.1.62; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 